Popular on TelAve
- Conexwest: Shipping Containers Are Powering the Next Generation of Bitcoin Mining Infrastructure
- Quadcode Acquires Significant Stake in Game 7, LLC - The Parent Company for FPFX Tech and PropAccount.com
- New Book Warring From the Standpoint of the Throne Room Calls Believers to Pray From Victory
- At 25, She Became One of the Youngest AAPI Female Founders to Win One of the World's Most Prestigious Design Awards for a Lamp That Makes You Smile
- Simpalm Staffing Services Launched its Refreshed Website for Remote Staffing Services
- $6 Million Funding Secured as Retail Expansion, Operational Streamlining, and Asset-Light Strategy Position the Company for Accelerated Growth $SOWG
- HRC Fertility to Celebrate Grand Opening of New Beverly Hills Location During National Infertility Awareness Week
- Pager Call Systems Joins The Brighton Technologies Group Family
- Custom Wooden Token Manufacturer Celebrates 10 Years of Helping Brands Stay Top of Mind
- Pregis Expands Wind Energy Use, Advancing Progress Toward Net Zero by 2040
Global Biopsy Device Market is anticipated to surpass USD 2.8 Billion by the year end of 2025
TelAve News/10604714
Renub Research report titled "Biopsy Devices Market, Global Forecast, by Products (Biopsy Needles, Guidance Systems, Biopsy Guns Reagents and kits and others), Regions (North America, Europe, Asia-Pacific & Rest of the World), Application, Companies" captures a detailed analysis of global Biopsy Devices market and volume and provides an all-encompassing analysis of the key growth drivers and preventive factors, key players and their projections for the future. Global Biopsy Device Market is anticipated to surpass USD 2.8 Billion by the year end of 2025.
Biopsy refers to surgical removal of a tissue from any human organ in order to know the existence of a particular cancer disorder. This procedure is performed by surgeons, cardiologists and radiologists. The use of each biopsy tool can vary depending on the type of organ being considered.
Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=defibrillator-market-forecast-p.php
The main factor driving market growth is minimal invasive surgery which mitigates risks and side effects. In addition, increasing awareness about chronic disease diagnosis increases demand for advanced biopsy technologies such as stereotactic-guided biopsy. Nevertheless, high biopsy procedure costs and limited availability of skilled professionals in low-income countries are hampering market growth.
More on TelAve News
Biopsy was one of the main cancer disease screening methods and is commonly used in breast, hair, and prostate cancer diagnosis. According to the World Cancer Report, cancer rates will continue to rise to 15 million new cases by 2020. Therefore, the market is expected to increase with the rising incidence of cancer cases and advancements in biopsy devices.
Most countries have services for early breast cancer detection. These policies will therefore increase the rate of adoption of biopsy devices and thus have a positive impact on the development of the industry of biopsy devices in the foreseeable future.
Request a free Brochure copy of the report: https://www.renub.com/request-brochure-page.php?gturl=biopsy-devices-market-global-forecast-p.php
Market Summary:
By Segments: The product-based demand for biopsy devices is categorized into Biopsy Needles, Guidance Systems, Biopsy Guns, Reagents and kits and others. The needle-based biopsy tools gained the largest market share of biopsy products in 2018. This segment is also expected to grow at the fastest rate in the forecast period due to an increase in breast cancer, gastrointestinal tract diseases and soft tissue sarcomas.
By Application: Breast biopsy in the product segment which has produced the highest revenue in 2018 and is expected to maintain its dominance over the forecast period, according to the report. This is due to an increase in the number of patients with breast cancer who have been observed across the globe over the years and are expected to continue this trend in the future.
More on TelAve News
By Regions: Due to the high availability of trained medical professionals, the existence of well-developed infrastructure facilities and the presence of a number of key players, North America holds the largest market share in 2018 and is expected to maintain its dominance during the forecast period.
If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team.
Key Topics Covered :
1. Introduction
2. Research Methodology
3. Executive Summery
4. Global – Biopsy Devices Market
5. Market Share – Global Biopsy Devices
6. By Product - Biopsy Devices Market
7. By Application - Biopsy Devices Market
8. By Region - Biopsy Devices Market
9. By End - User - Biopsy Devices Market
10. Becton, Dickinson and Company – Company Analysis
11. B. Braun Melsungen AG – Company Analysis
12. Cardinal Health, Inc. – Company Analysis
13. Olympus Corporation – Company Analysis
14. Boston Scientific Corporation – Company Analysis
15. Medtronic plc – Company Analysis
16. Hologic, Inc. – Company Analysis
17. Growth Drivers
18. Challenges
Contact Us
Email: info@renub.com
Phone: +1-678-302-0700
Web: www.renub.com
Biopsy refers to surgical removal of a tissue from any human organ in order to know the existence of a particular cancer disorder. This procedure is performed by surgeons, cardiologists and radiologists. The use of each biopsy tool can vary depending on the type of organ being considered.
Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=defibrillator-market-forecast-p.php
The main factor driving market growth is minimal invasive surgery which mitigates risks and side effects. In addition, increasing awareness about chronic disease diagnosis increases demand for advanced biopsy technologies such as stereotactic-guided biopsy. Nevertheless, high biopsy procedure costs and limited availability of skilled professionals in low-income countries are hampering market growth.
More on TelAve News
- UK Financial Ltd Tokenized LTNS 1, A $1.1 T Asset-Backed ERC-3643 Security Token with 11 On-Chain Contracts Verifying, Compliant Real-World Value
- SelfCare is now HealthCare across America
- Homeowner Prep Announces Strategic Language Shift: Replacing "Renters" with "Future Homeowners" to Inspire Wealth-Building Mindsets
- LiposoMore™ Redefines Bioavailability: Joyful Nutritional Launches High-Performance Liposomal Vitamin C and Iron for the Global Supplement Market
- GDE Tree Services Expands Operations into Sydney, NSW
Biopsy was one of the main cancer disease screening methods and is commonly used in breast, hair, and prostate cancer diagnosis. According to the World Cancer Report, cancer rates will continue to rise to 15 million new cases by 2020. Therefore, the market is expected to increase with the rising incidence of cancer cases and advancements in biopsy devices.
Most countries have services for early breast cancer detection. These policies will therefore increase the rate of adoption of biopsy devices and thus have a positive impact on the development of the industry of biopsy devices in the foreseeable future.
Request a free Brochure copy of the report: https://www.renub.com/request-brochure-page.php?gturl=biopsy-devices-market-global-forecast-p.php
Market Summary:
By Segments: The product-based demand for biopsy devices is categorized into Biopsy Needles, Guidance Systems, Biopsy Guns, Reagents and kits and others. The needle-based biopsy tools gained the largest market share of biopsy products in 2018. This segment is also expected to grow at the fastest rate in the forecast period due to an increase in breast cancer, gastrointestinal tract diseases and soft tissue sarcomas.
By Application: Breast biopsy in the product segment which has produced the highest revenue in 2018 and is expected to maintain its dominance over the forecast period, according to the report. This is due to an increase in the number of patients with breast cancer who have been observed across the globe over the years and are expected to continue this trend in the future.
More on TelAve News
- Tuckwell Machinery Expands CNC Range to Support Australian Cabinet Makers
- The Inner Power of Emotional Self-Leadership
- Dr. Nadene Rose Shares the Secret to True Success: Faith, Obedience, and Divine Purpose
- Understanding Unexpected Death: Why Independent Autopsies Matter in Cases Without Clear Cause
- Epic Pictures Group Sets North American Release Date for the Thriller NO ORDINARY HEIST
By Regions: Due to the high availability of trained medical professionals, the existence of well-developed infrastructure facilities and the presence of a number of key players, North America holds the largest market share in 2018 and is expected to maintain its dominance during the forecast period.
If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team.
Key Topics Covered :
1. Introduction
2. Research Methodology
3. Executive Summery
4. Global – Biopsy Devices Market
5. Market Share – Global Biopsy Devices
6. By Product - Biopsy Devices Market
7. By Application - Biopsy Devices Market
8. By Region - Biopsy Devices Market
9. By End - User - Biopsy Devices Market
10. Becton, Dickinson and Company – Company Analysis
11. B. Braun Melsungen AG – Company Analysis
12. Cardinal Health, Inc. – Company Analysis
13. Olympus Corporation – Company Analysis
14. Boston Scientific Corporation – Company Analysis
15. Medtronic plc – Company Analysis
16. Hologic, Inc. – Company Analysis
17. Growth Drivers
18. Challenges
Contact Us
Email: info@renub.com
Phone: +1-678-302-0700
Web: www.renub.com
0 Comments
Latest on TelAve News
- Red5 Taps PubNub to Power the Next Era of Real-Time Interactive Streaming
- Shoutout Joseph Neibich aka Nybyk
- Meet Joseph Neibich aka Joseph Nybyk of Beachwood Canyon
- LARUS Launches Business Continuity Framework for IPv4-Dependent Networks
- KeysCaribbean Offers 'Skip-the-Crowds' Savings With 15 Percent Off April Stays
- Supply & Demand Chain Executive Names Puga Sankara as Recipient of 2026 Pros to Know Award
- AI Disruption Meets Marine Scale: Off The Hook YS, Inc. (N Y S E American: OTH) Targets Breakout Growth with NextBoat Launch and Aggressive Expansion
- Targeting the Billion-Dollar U.S. Countermeasure Market With AI-Driven Biodefense Platform: Lunai Bioworks (N A S D A Q: LNAI)
- New Global Standard for Transparency Across Critical Resources and Energy Markets: SMX (Security Matters) PLC (N A S D A Q: SMX)
- Forced Psychiatric Hospitalization Fails Vulnerable People: CCHR Urges Repeal Amid Rising U.S. Policies
- Surging Into High-Performance AI With $AMD Partnership, Patent Expansion, and Strengthened Balance Sheet: Avalon GloboCare Corp. (N A S D A Q: ALBT)
- Kiko Nation Launches Mobile App to Modernize Livestock Management and Digital Animal Registry
- NEW MANAGEMENT BOOK: Creating a Joy-Centric Culture
- QuickTrack by Datalex Transforms Retail Promoter Management with Claude AI and Real-Time Insights
- Kaltra Introduces Seasonal Discounts on Replacement Coils for Carrier, York, and Trane Chillers
- Evolve Construction Mobilizes Commercial Storm Response Across Illinois With AI-Powered Damage Documentation and Public Adjusters Partnership
- The World's First Fully Regenerative Economy: Securing Energy, Food, and a Clean Planet
- The State of Law Firm Marketing: Top Companies, Awards, and Resources
- USA Best Book Awards Finalist What Love Leaves Behind Releases March 24
- Inkdnylon Custom Apparel Launches Cost-Saving System for Promotional Products and Custom Apparel in Chicago